EU
SAGE

Emory University’s Sage Therapeutics SAGE Stock Holding History

Emory University’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17,998
Closed -$2.54M – 48
2018
Q3 		$2.54M Buy
17,998
+2,503
+16% +$386K 1.66% 23
2018
Q2 		$2.42M Sell
15,495
-637
-4% -$100K 1.61% 26
2018
Q1 		$2.6M Buy
+16,132
New +$2.74M 1.86% 12

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Emory University's SAGE Position: Q4 2018 in Review

Emory University sold out of Sage Therapeutics (SAGE) in Q4 2018, closing a stake of 17,998 shares — an estimated $2.54M sold.

Emory University first reported a position in SAGE in Q1 2018 and held it in 3 quarters. The position peaked at $2.6M in Q1 2018. 249 funds tracked by Wall St. Rank hold SAGE as of Q4 2018.

  • Emory University reported no remaining Sage Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Emory University sold 17,998 Sage Therapeutics shares in Q4 2018, an estimated $2.54M.
  • Emory University first reported a position in Sage Therapeutics in Q1 2018 and held it in 3 quarters.
  • Emory University's Sage Therapeutics position peaked at $2.6M in Q1 2018.
  • 249 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2018.

Based on Emory University's 13F filing for Q4 2018, filed 12 Feb 2019.